Where Chinese Investors Meet Global Investment News and Opportunities

中國投資者探索環球投資新聞及機遇

China Biologic to Acquire TianXinFu, a Device Company, in $536 Million Deal

China Biologic to Acquire TianXinFu, a Device Company, in $536 Million Deal

China Biologic Products, a plasma company headquartered in Beijing, will acquire an 80% interest in TianXinFu (Beijing) Medical Appliance in an all-stock deal worth $536 million. According to China Biologic, TianXinFu is China’s largest maker of biomaterial scaffolds, which aid new tissue regeneration and organ repair. China Biologic will issue 5.5 million shares to PW Medtech to pay for the acquisition. Its stock price fell almost 15% after the deal was announced.

Source: China Biotoday

Add Comment

Your email address will not be published. Required fields are marked *